Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyoma × Clomiphene × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 46 Infertility 18 Anovulation 10 Hyperandrogenism 2 Vitamin D Deficiency 1 Rare Diseases 1 Prolactinoma 1 Primary Ovarian Insufficiency 1 Pathologic Processes 1 Motor Activity 1 Leiomyoma 1 Insulin Resistance 1 Infertility, Female 1 Hypogonadism 1 Hyperprolactinemia 1 Hyperinsulinism 1 Endocrine System Diseases 1 Dry Eye Syndromes 1

Interventions

ulipristal acetate 18 Uterine Myomectomy 17 telapristone acetate 16 vilaprisan 11 Uterine Artery Embolization 10 relugolix 9 Leuprolide 9 asoprisnil 7 Mifepristone 7 ulipristal 6 estradiol, norethindrone drug combination 6 elagolix 6 Tranexamic Acid 6 Hysterectomy 6 Estradiol 6 Bupivacaine 6 Norethindrone Acetate 5 linzagolix 4 epigallocatechin gallate 4 Sodium Chloride 4 Saline Solution 4 Letrozole 4 Vitamin B 6 3 Radiofrequency Ablation 3 Misoprostol 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 cetrorelix 2 Vitamin D 2 Tea 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04177693 2023-06-05

Pharmacokinetics and Hepatic Safety of EGCG

Yale University

Phase 1 Completed

39 enrolled 18 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡